Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT05570305
Status:
COMPLETED
Last Update Posted:
2025-04-30
First Post:
2022-10-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
Sponsor:
University Medical Center Groningen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-05
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-05
First Submit QC Date:
None
Study First Post Date:
2022-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-25
Last Update Post Date:
2025-04-30
Last Update Post Date Type:
ACTUAL